Markets:

Overview

News

Currencies

International

Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

59.05 UNCHANGED

Streaming Delayed Price Updated: 4:15 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Tempus AI Shares Are Trading Higher Monday: What's Going On? ↗

October 20, 2025

Tempus AI (NASDAQ:TEM) shares are trading higher Monday after the company announced its subsidiary, Ambry Genetics, published a peer reviewed study in Genetics in Medicine.

Via Benzinga

Topics Artificial Intelligence

AI Stocks Ride a Volatile Wave Amidst Unprecedented Growth and Bubble Fears

October 20, 2025

October 20, 2025 - The artificial intelligence (AI) sector continues to be a dominant force in the financial markets, driving significant gains and pushing major indices to new highs. Despite a...

Via MarketMinute

Topics Artificial Intelligence Economy Fraud

Beyond The Numbers: 7 Analysts Discuss Tempus AI Stock ↗

October 20, 2025

Via Benzinga

Topics Artificial Intelligence

Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark ↗

October 16, 2025

Via Stocktwits

Topics Artificial Intelligence

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

October 20, 2025

From Ambry Genetics

Via Business Wire

IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio? ↗

October 19, 2025

Top large-cap losers last week included IonQ, Tempus AI, AeroVironment, Astera Labs, Nebius, Kratos, F5, Klarna, Leonardo DRS, and First Horizon, driven by sector pullbacks, policy concerns on defense...

Via Benzinga

Topics Artificial Intelligence

Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership ↗

October 17, 2025

Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading following the news.

Via Benzinga

Topics Artificial Intelligence

Whitehawk Therapeutics Stock Is Trading Higher Thursday: What's Going On? ↗

October 16, 2025

Whitehawk Therapeutics shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI to support the development of its oncology pipeline.

Via Benzinga

Topics Artificial Intelligence

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

October 16, 2025

From Tempus AI, Inc.

Via Business Wire

Tempus AI Hits $100—Are Shares Due for a Pullback? ↗

October 15, 2025

After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction.

Via MarketBeat

Topics Artificial Intelligence Government Initial Public Offering

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

October 15, 2025

From Tempus AI, Inc.

Via Business Wire

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗

October 15, 2025

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.

Via Benzinga

Topics Artificial Intelligence

Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any? ↗

October 10, 2025

Shared stocks between Nancy Pelosi and Cathie Wood include Alphabet, Amazon, NVIDIA, and Tempus AI. They also both own stakes in private company Databricks.

Via Benzinga

Topics Artificial Intelligence

Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025 ↗

October 10, 2025

Track Nancy Pelosi's 2025 stock trades. Disclosures reveal a Tempus AI (TEM) options buy nets huge gains along with a Broadcom move.

Via Benzinga

Topics Artificial Intelligence

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

October 09, 2025

From Tempus AI, Inc.

Via Business Wire

Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall ↗

October 09, 2025

Tempus AI (TEM) stock has soared past $100, giving a 60% boost to billionaire Cliff Asness' TEM position in the AI-diagnostic stock.

Via Benzinga

Topics Artificial Intelligence

Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock ↗

October 08, 2025

Tempus AI stock nudged higher after hours following insider sales by COO Ryan Fukushima's spouse under a pre-arranged trading plan.

Via Benzinga

Topics Artificial Intelligence

These 5 Beaten-Down Tech Stocks Could Catch Fire Next ↗

October 08, 2025

Highly shorted stocks with positive growth outlooks and improving market support are set up for short squeezes: this is a look at five.

Via MarketBeat

Topics Artificial Intelligence

Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200% ↗

October 08, 2025

An AI stock disclosed as a new 2025 purchase by Nancy Pelosi is up over 200% since she took the position in January.

Via Benzinga

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 03, 2025

Via Benzinga

Why Tempus AI Stock Was Motoring Higher This Week ↗

October 03, 2025

A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist.

Via The Motley Fool

Topics Artificial Intelligence

AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants

October 01, 2025

As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This...

Via MarketMinute

Topics Artificial Intelligence

Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On? ↗

October 01, 2025

Shares of Tempus AI Inc (NASDAQ: TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here's what investors need to know.

Via Benzinga

Topics Artificial Intelligence

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

October 01, 2025

From Ambry Genetics

Via Business Wire

Affirm Holdings, Oklo, Tempus AI Are Among Top 10 Large Cap Losers Last Week (Sep. 22- Sep. 26): Are The Others In Your Portfolio? ↗

September 28, 2025

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

Via Benzinga

Topics Artificial Intelligence

3 Healthcare Stocks Using AI to Drive Growth ↗

September 27, 2025

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

Via MarketBeat

Topics Artificial Intelligence

What Are 2 Great Tech Stocks to Buy Right Now? ↗

September 27, 2025

These two tech stocks could deliver big returns for investors willing to hold for the long term.

Via The Motley Fool

Topics Artificial Intelligence Stocks

7 Analysts Have This To Say About Tempus AI ↗

September 26, 2025

Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings,...

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.